Operator: Good day and welcome to the Second Quarter 2026 Harvard Bioscience Earnings Conference Call. [Operator Instructions ...
National recognition comes as Daré Bioscience advances a multi-product women’s health strategy across commercialization, clinical development and first-in-category innovationSAN DIEGO, Aug. 18, 2026 ...
The aggregate gross proceeds to the Company from the registered direct offering at the closing are expected to be $6.0 million before deducting placement agent fees and estimated offering expenses ...
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the third quarter fiscal 2026 ended June 30, 2026 ...
Q2 2026. Management View "In June, we launched Flora Sync LF5, the first product in our DARE to RESTORE line." (CEO, President, Pri ...
Twist Bioscience Corporation TWST stock is up on Monday as the company reported its fiscal 2026 third-quarter financial results and raised fiscal 2026 guidance. The life science company reported an ...
Twist Bioscience Corporation (Nasdaq: TWST) ("Twist"), a mid-cap growth and value biotech company, today announced the commencement of an underwritten public offering of $250.0 million of shares of ...
Q3 FY2026 earnings call: record revenue, raised FY2026 guidance, and AI drug discovery growth outlook—read key takeaways now.
InvestorsHub on MSN
Harvard Bioscience beats Q2 estimates and raises 2026 revenue guidance
Harvard Bioscience Inc. (NASDAQ:HBIO) reported better-than-expected second-quarter results on Tuesday and raised its ...
Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today announced ...
As of Monday, August 10, Twist Bioscience Corporation’s TWST share price has surged by 5.03%, which has investors questioning ...
Twist Bioscience Corporation (Nasdaq: TWST) (“Twist”), a mid-cap growth and value biotech company, today announced the pricing of an upsized underwritten public offering of 3,125,000 shares of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results